Avidity Biosciences (RNA) EPS (Weighted Average and Diluted): 2020-2025
Historic EPS (Weighted Average and Diluted) for Avidity Biosciences (RNA) over the last 5 years, with Sep 2025 value amounting to -$1.27.
- Avidity Biosciences' EPS (Weighted Average and Diluted) fell 95.38% to -$1.27 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.19, marking a year-over-year decrease of 44.98%. This contributed to the annual value of -$2.89 for FY2024, which is 0.69% up from last year.
- Avidity Biosciences' EPS (Weighted Average and Diluted) amounted to -$1.27 in Q3 2025, which was down 4.96% from -$1.21 recorded in Q2 2025.
- Avidity Biosciences' EPS (Weighted Average and Diluted)'s 5-year high stood at -$0.64 during Q2 2021, with a 5-year trough of -$1.27 in Q3 2025.
- In the last 3 years, Avidity Biosciences' EPS (Weighted Average and Diluted) had a median value of -$0.79 in 2024 and averaged -$0.84.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first increased by 28.26% in 2023, then plummeted by 95.38% in 2025.
- Avidity Biosciences' EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.84 in 2021, then dropped by 5.95% to -$0.89 in 2022, then climbed by 10.11% to -$0.80 in 2023, then dropped by 1.25% to -$0.81 in 2024, then plummeted by 95.38% to -$1.27 in 2025.
- Its last three reported values are -$1.27 in Q3 2025, -$1.21 for Q2 2025, and -$0.90 during Q1 2025.